New drug shows promise in the fight against malignant melanoma
Sunday September 27, 2009
A research team led by associate professor Gavin Robertson at the College of Medicine has developed a new drug based on the anti-cancer compounds in cruciferous vegetables. Tests in mice suggest that this new drug is both safer and more potent than conventional therapies in targeting the most deadly form of skin cancer [read more....].
Vegetable-based drug could inhibit melanoma
Sunday, March 01, 2009
Compounds extracted from green vegetables such as broccoli and cabbage could be a potent drug against melanoma, according to cancer researchers. Tests on mice suggest that these compounds, when combined with selenium, target tumors more safely and effectively than conventional therapy. "There are currently no drugs to target the proteins that trigger melanoma," said Gavin Robertson, associate professor of pharmacology, pathology and dermatology, Penn State College of Medicine [read more..]
The Medical Minute: Melanoma – the most deadly form of skin cancer
Tuesday, May 20, 2008
Did you know that May is melanoma month and that the number of people diagnosed with melanoma -- the deadliest of skin cancers -- increases by about 4 percent each year with one person dying from this disease every hour? At the current rate of increase, it is predicted that melanoma will affect 1 in 50 U.S. citizens by 2010. Unlike people diagnosed with other common cancers, including prostate and breast cancer, people with melanoma have roughly the same therapies available and chance for survival as they did 30 years ago, according to the latest edition of The Medical Minute, a service of the Penn State Hershey Medical Center [read more...]
Scientists identify interacting proteins key to melanoma development
Tuesday, May 06, 2008
Researchers have discovered how a mole develops into melanoma by showing the interaction of two key proteins involved in 60-70 percent of tumors. The Penn State scientists also demonstrate that therapeutic targeting of these proteins is necessary for drugs to effectively treat this deadly form of cancer [read more...]
Nanomedical approach targets multiple cancer genes, shrinks tumors
September 15, 2008
Hershey, Pa. — Nanoparticles filled with a drug targeting two genes that trigger
melanoma could offer a potential cure for this deadly disease, according to cancer researchers. The treatment, administered through an ultrasound device, demonstrates a safer and more effective way of targeting cancer-causing genes in cancer cells without harming normal tissue [read more....]
